Cutting Edge: Cbl-b: One of the Key Molecules Tuning CD28- and CTLA-4-Mediated T Cell Costimulation-Reference-Cited by-同舟云学术

Cutting Edge: Cbl-b: One of the Key Molecules Tuning CD28- and CTLA-4-Mediated T Cell Costimulation

Published:2004-12-07 Issue:12 Volume:173 Page:7135-7139
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Li Dongdong,Gál István,Vermes Csaba,Alegre Maria-Luisa,Chong Anita S. F.,Chen Lieping,Shao Qing,Adarichev Vyacheslava,Xu Xuemei,Koreny Tamas,Mikecz Katalin,Finnegan Alison,Glant Tibor T.,Zhang Jian

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation

2. The expanding world of co-stimulation: the two-signal model revisited

3. The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function

4. T-cell regulation by CD28 and CTLA-4

5. Molecular Regulation of the IL-2 Gene: Rheostatic Control of the Immune System

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy;Bioorganic & Medicinal Chemistry;2024-03

2. Advances in research on potential inhibitors of multiple myeloma;European Journal of Medicinal Chemistry;2023-12

3. CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer;Current Molecular Medicine;2023-07

4. Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets;Journal for ImmunoTherapy of Cancer;2023-05

5. Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events;Cancers;2023-03-06